Innovation of a Vaccine Against All Types of Cancer

Russian scientists have developed a vaccine that is effective against all types of cancer, successfully passing tests conducted on laboratory mice. Russian academic Alexander Gintsburg stated at the St. Petersburg International Economic Forum that "the Russian vaccine against all types of cancer successfully passed tests conducted on mice with melanoma. Researchers observed that after 15 days following vaccination, when the immune system begins to function, there was a significant difference in tumor size between vaccinated and unvaccinated animals. The results showed that unvaccinated mice died between 19 to 22 days after vaccination, while vaccinated mice are still alive to this day." Gintsburg added that "the vaccine was developed using mRNA technology, and it is expected to be administered to cancer patients either by injection into the malignant tumor directly or intramuscularly depending on the patient's condition. This is because if administered in the form of drops orally, it will reach the liver due to its lipid coating, whereas injecting it into the tumor or muscles allows it to distribute evenly throughout the body."